TAILORx Phase 3 trial

June 12, 2019

Combining 2 Assessments of Breast Cancer Recurrence Risk May Help Guide Use of Adjuvant Chemotherapy

News

Adding an assessment of a woman’s clinical risk to Genomic Health‘s genomic test Oncotype DX to estimate the likelihood of breast cancer recurrence may spare more young women from having ... Read more

June 20, 2018

Most Women with Early Breast Cancer Can Forgo Chemotherapy, Large Trial Finds

News

Seventy percent of women with the most common form of early breast cancer can avoid chemotherapy after surgery, according to a landmark Phase 3 clinical trial. The trial’s results, “Adjuvant ... Read more